Want to join the conversation?
$BSX's gross margin for 1Q16 rose to 70.8% from 70.6% last year. This rise has positive impact of cost reductions as result of restructuring and other process improvement programs. Partially offset was negative impact of pricing declines and step-up of inventory acquired as part of AMS Portfolio acquisition from manufacturing cost to fair value.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)